Thermo Fisher Scientific Expands Kentucky Operations with $47.8 Million Investment

28 June 2024 | Friday | News

PPD Clinical Research Business to Create Over 250 Jobs, Enhancing Capabilities in Highland Heights and New Covington Site for Advanced Pharmaceutical and Biotech Solutions
Image Source : Public Domain

Image Source : Public Domain

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expansion of its central laboratory operations in Kentucky dedicated to accelerating pharmaceutical and biotech customers’ delivery of safe, effective medicines to patients.

The business will expand its sample management and biorepository operations in a new 65,000-square-foot space in Covington, enabling further capability expansion at its existing site in nearby Highland Heights. Thermo Fisher’s $47.8 million investment is expected to create more than 250 new jobs across the two sites over the next eight years, with renovation and construction anticipated to begin later this year.

The PPD clinical research business has operated a central lab operation in Highland Heights since 2002, and today it includes central lab services, biomarker operations, sample management and testing to support new therapeutics, including vaccines and cell and gene therapy products. The renovation of an existing building on West 38th Street in Covington will significantly expand the business’ labs footprint.

“Our central lab plays a vital role in helping our customers make timely, efficient and informed decisions about their clinical trials and ensure patient safety,” said Leon Wyszkowski, president, analytical services, clinical research, Thermo Fisher Scientific. “Our expansion will enhance their ability to advance life-changing research. We are excited to expand into Covington and grow our operations in Highland Heights as a vital part of our global labs capabilities serving our customers. We value the support of state and local officials as we continue to hire talented colleagues to advance our company’s Mission to enable our customers to make the world healthier, cleaner and safer.”

“The commonwealth is seeing tremendous growth in its health care and life-sciences sectors, providing high-paying, quality jobs for Kentucky residents across the state,” said Kentucky Gov. Andy Beshear. “I am thrilled to see Thermo Fisher once again choose Kentucky to locate and expand its business. I look forward to the company’s continued success here in the commonwealth as this continued investment will be a welcomed addition to the Northern Kentucky region.”

The Highland Heights central lab, which employs more than 600 analytical laboratory staff, scientific and support professionals, and Ph.D.-level scientists, offers safety testing including automated chemistry, urinalysis and hematology, anatomic pathology, flow cytometry, microbiology and molecular assays. The central lab also offers a wide variety of other services, such as clinical sample management, processing and storage, kit design and preparation for collection of clinical samples, and sample testing services. The biomarker lab provides support for regulated biomarkers with immunoassays, flow cytometry and molecular assays.

In addition to the Highland Heights facility, Thermo Fisher’s clinical research business has biomarker and central labs in Brussels, Belgium, and Singapore; bioanalytical, biomarker and vaccine sciences labs in Richmond, Virginia; bioanalytical and good manufacturing practices (GMP) labs in Middleton, Wisconsin; a GMP lab in Athlone, Ireland; and bioanalytical, biomarker, vaccine sciences and central labs in Suzhou, China.


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in